Feature|Articles|February 15, 2024
- Pharmaceutical Executive: February 2024
- Volume 44
- Issue 1
Pharmaceutical Executive: February 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
Central to the Missionalmost 2 years ago
Two Frameworks for Orphan Drug IDN Launch Planningalmost 2 years ago
Sustainability and Progress Continue to Make Headlines in 2024almost 2 years ago
Building Resiliency: Essential Leadership Principles for 2024almost 2 years ago
Will Strong Early-Year Vibes Translate to More Stabilization Ahead?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
Taking Advantage of ‘Hidden Gem’ Talent Hubs
4
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
5